SCHEMBL16711601

SCHEMBL16711601

COC[C@@]12CC[C@@H](CC1=O)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9945767 0.79 HSD11B1 (0.33)
SCHEMBL16711606 0.76
SCHEMBL6714928 0.75 SLC6A3 (0.37)
SCHEMBL1697305 0.71
SCHEMBL21334351 0.70
SCHEMBL18306964 0.70
SCHEMBL12203400 0.69
SCHEMBL11656923 0.67 NR1I2 (0.32)
SCHEMBL17893058 0.65
SCHEMBL6714991 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066082-B1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES HOFFMANN LA ROCHE (CH) 2017-12-20 EP disclosed
WO-2015067575-A1 5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORC MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2015-05-14 WO disclosed